HHS Defends Part B IPI Demo, Shores Up Support From Patient Advocate

Updated Story HHS hit back at conservative critics of its international price referencing Medicare Part B demo Thursday (Nov. 6) in a blog post authored by its new senior adviser for drug pricing reform , John O’Brien. HHS Secretary Alex Azar also discussed the Part B demo in a meeting with a supportive patient group that advocates for lower drug prices. O’Brien characterized the Part B demo as a “new initiative on competition and negotiation,” and criticized...